|
Bifidobacterium
|
B03.510.024.100 |
|
|
Erythrokeratodermia Variabilis
|
C17.800.827.337 |
|
|
Cyclacillin
|
D03.633.100.300.750.249 |
|
|
Pharmacoepidemiology
|
H01.158.703.045 |
|
|
Ethylmaleimide
|
D02.241.081.337.502.524.418 |
|
|
Maleimides
|
D02.241.081.337.502.524 |
|
|
Monocarboxylic Acid Transporters
|
D12.776.157.530.450.074.500.400 |
|
|
Barium Sulfate
|
D01.875.800.800.850.075 |
|
|
Genes, T-Cell Receptor beta
|
G05.360.340.024.340.475.080 |
|
|
5-Hydroxytryptophan
|
D12.125.072.050.850.479 |
|
|
Tryptophan
|
D12.125.072.050.850 |
|
|
Keratoconjunctivitis
|
C11.204.564.585 |
|
|
APOBEC-3G Deaminase
|
D08.811.277.151.486.250.500.750 |
|
|
3' Flanking Region
|
G05.360.340.024.340.137.290 |
|
|
Logical Observation Identifiers Names and Codes
|
L01.453.245.945.500 |
|
|
Sodium Glutamate
|
D12.125.119.409.349.575 |
|
|
Neuropharmacology
|
H01.158.703.030 |
|
|
5' Flanking Region
|
G05.360.340.024.340.137.295 |
|
|
Polyribonucleotide Nucleotidyltransferase
|
D08.811.913.696.445.735.532 |
|
|
Amlodipine, Valsartan Drug Combination
|
D03.383.725.203.065.750 |
|
